GlassScriptPhysician profile
Van B Luong
NPI 1699243410
$3,431.15
in general payments reported to CMS, 2019-2025
17 companies · $272 in 2025
The $272 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $147 · 2020: $239 · 2021: $463 · 2022: $623 · 2023: $1,242 · 2024: $445 · 2025: $272.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,678 · Travel and Lodging: $281.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,678.30 |
| Travel and Lodging | $280.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Vision Care, INC. | $1,163.54 | 2020-2023 | Acuvue |
| Bausch & Lomb Americas INC. | $353.24 | 2022-2025 | Miebo, Xiidra, Infuse |
| Oyster Point Pharma, INC. | $353.10 | 2022-2025 | Tyrvaya |
| Alcon Vision LLC | $285.57 | 2019-2025 | Total30, Precision7 |
| Dompe US, INC. | $190.37 | 2021-2025 | Oxervate |
| Novartis Pharmaceuticals Corporation | $182.48 | 2021-2023 | |
| Sun Pharmaceutical Industries INC. | $165.32 | 2019-2024 | Cequa |
| Tarsus Pharmaceuticals, INC. | $132.66 | 2024-2025 | Xdemvy |
| Abb Con-Cise Optical Group LLC | $121.75 | 2021-2023 | Contact Lens, Spectacle Lenses |
| Aerie Pharmaceuticals, INC. | $115.18 | 2019-2021 | |
| Visioneering Technologies, INC. | $85.76 | 2020 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $82.48 | 2019-2021 | |
| Coopervision INC. | $73.44 | 2023-2024 | Myday Contact Lens, Paragon Crt |
| Abbvie INC. | $49.93 | 2023-2025 | |
| Allergan, INC. | $33.30 | 2020 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eyevance Pharmaceuticals LLC | $29.88 | 2020 | |
| Harrow Eye, LLC | $13.15 | 2024 | Vevye |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Van Luong listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.